Breast Cancer Monoclonal Antibodies Market Size to grow by USD 19.2 billion between 2024-2028
Technavio, a leading provider of market research reports, has released its latest study on Breast Cancer Monoclonal Antibodies Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges.
Key Highlights:
The market size is estimated to grow by USD 19.2 billion, at a CAGR of 13.97% during the forecast period. The Breast Cancer Monoclonal Antibodies market is poised for significant growth as an increasing number of these treatments receive regulatory approval. This expanding portfolio of options caters to the demand for effective and targeted therapies. Notably, Merck's pembrolizumab (Keytruda) was approved by the US FDA in July 2021 for neoadjuvant and adjuvant treatment of high-risk, early-stage Triple-Negative Breast Cancer (TNBC), marking a significant addition to the market. Furthermore, a robust product pipeline indicates ongoing research and development efforts, promising the introduction of innovative therapies.
For insights on company offerings- Request a sample report!
The Breast Cancer Monoclonal Antibodies market represents a significant business opportunity due to the increasing prevalence of breast cancer and the growing demand for targeted therapies. Monoclonal antibodies, as precision oncology tools, offer effective treatment options by specifically targeting cancer cells. Key market players are investing in research and development to launch novel monoclonal antibodies and expand their product portfolios, thereby driving market growth.
About Technavio
Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/